Freiburg Spital

Fribourg 1708

1 studies enrolling now · 2 studies all time

What they study most

Extensive Stage Small Cell Lung Cancer, Small Cell Lung Cancer (SCLC)

Studies at this site

• Subcutaneous Tarlatamab in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-308) — Recruiting now
• Study Comparing Tarlatamab With Standard of Care Chemotherapy in Relapsed Small Cell Lung Cancer — Running, not enrolling